Stock Markets July 9, 2026 08:32 AM

Premarket Movers: Enovix and Forte Rally as Futures Mix; PepsiCo Edges Lower

Enovix names former Apple executive as COO; Forte posts positive vitiligo data; markets weigh geopolitical tensions against semiconductor strength

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
PEP FBRX

U.S. index futures showed a mixed picture on Thursday as investors balanced rising geopolitical tensions between the United States and Iran with strength in semiconductor-related names. In premarket trading, Enovix and Forte Biosciences were among the top gainers after corporate leadership and clinical updates, while PepsiCo slipped after mixed quarterly results.

Premarket Movers: Enovix and Forte Rally as Futures Mix; PepsiCo Edges Lower
PEP FBRX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • U.S. futures were mixed: Dow futures down 85 points (-0.2%), S&P 500 futures up 12 points (+0.2%), Nasdaq 100 futures up 176 points (+0.6%).
  • Enovix rose 17% after naming Michael Vyvoda as COO to oversee global manufacturing and supply chain as production ramps in Malaysia and South Korea; Forte Biosciences jumped 12% on positive Phase 1b vitiligo results.
  • Rackspace gained 8% on a strategic partnership with Palantir to deploy enterprise AI in regulated environments; PepsiCo fell 1.8% after mixed Q2 results where revenue topped estimates but adjusted EPS slightly missed.

U.S. stock index futures were mixed on Thursday as investors weighed escalating tensions between the United States and Iran against a continued rebound in semiconductor shares.

By 07:09 ET (11:09 GMT), the Dow futures contract had slipped by 85 points, or 0.2%, S&P 500 futures had gained 12 points, or 0.2%, and Nasdaq 100 futures had advanced by 176 points, or 0.6%.

Technology and healthcare stocks led premarket gains, and traders also reacted to a series of corporate announcements including an executive hire, clinical trial data and a strategic partnership.


Notable premarket movers

  • Enovix surged 17% after appointing former Apple executive Michael Vyvoda as chief operating officer. Vyvoda, who previously helped scale AirPods manufacturing at Apple, will be responsible for Enovixs global manufacturing, supply chain and operations as the battery technology firm ramps up production in Malaysia and South Korea.
  • Forte Biosciences jumped 12% after reporting positive Phase 1b results for its vitiligo treatment FB102. The company said the therapy produced a statistically significant improvement versus placebo, with patients continuing to show benefits through 24 weeks.
  • Rackspace Technology gained 8% after announcing a strategic partnership with Palantir Technologies to create a framework for deploying enterprise artificial intelligence in regulated industries. The deal positions Rackspace as a preferred partner for implementing Palantirs Foundry and Artificial Intelligence Platform in sovereign clouds, private cloud and on-premises environments.
  • PepsiCo slipped 1.8% after posting mixed second-quarter results. Revenue exceeded Wall Street estimates on stronger sales across its snacks and beverages segments, but adjusted earnings per share came in just below analyst expectations, triggering some selling pressure.

These moves illustrate how company-specific developments - executive changes, clinical trial outcomes and commercial partnerships - can drive sharp premarket reactions, even as larger macro forces such as geopolitical tensions influence overall market tone. Technology and healthcare names in particular led the upside, while consumer staples saw modest weakness following PepsiCos earnings update.

Market participants will likely continue to assess the impact of external geopolitical news alongside earnings and strategic updates as the trading day progresses.

Risks

  • Escalating tensions between the United States and Iran create geopolitical uncertainty that can sway market sentiment and volatility - impacts multiple sectors including energy and broader equities.
  • Operational challenges as Enovix ramps up manufacturing in Malaysia and South Korea could affect the companys ability to scale production - relevant to the battery and technology supply chain sectors.
  • Earnings that fall short of analyst expectations, as seen with PepsiCos adjusted EPS, can prompt near-term selling pressure in consumer staples and related stocks.

More from Stock Markets

William Blair Opens Coverage of AMD at Market Perform, Cites Balanced Upside and Risks Jul 9, 2026 Gloo Holdings Shares Plunge After $3.25 Public Offering Is Priced Jul 9, 2026 SK Hynix Targets $149 ADR Price in Proposed U.S. Listing, Aiming for Record-Setting Debut Jul 9, 2026 Barclays Identifies Power-as-a-Service Leaders to Fuel AI Data Center Growth Jul 9, 2026 Lam Research Jumps in Pre-Market as Chip Complex Recovers Jul 9, 2026